Flag­ship's Mon­tai Health hires first CMO; Fi­nance leader to re­tire at J&J part­ner Xen­cor

Last year
Peer Review

Prime Med­i­cine show­cas­es its first in vi­vo edit­ing da­ta in mon­keys and mice

Last year
R&D
Cell/Gene Tx

San­thera’s va­morolone bags FDA ap­proval for Duchenne af­ter long jour­ney

Last year
Pharma

Eli Lil­ly’s ul­cer­a­tive col­i­tis drug ap­proved by FDA in crowd­ed mar­ket

Last year
Pharma
FDA+

Sanofi will spin out con­sumer unit, putting weight be­hind R&D ef­forts: ‘I have to in­vest in the sci­ence now’

Last year
R&D
Pharma

Study: On­col­o­gists who take phar­ma mon­ey are more like­ly to pro­vide low-val­ue treat­ments

Last year
Pharma
FDA+

Klick Health hires mar­ket ac­cess chief with Big Phar­ma ré­sumé

Last year
People
Marketing

Law­mak­ers push for faster, con­di­tion­al FDA ap­proval path­way for rare dis­ease drugs

Last year
Pharma
FDA+

UK reg­u­la­tors warn against fake Ozem­pic and Sax­en­da pens

Last year
Pharma
FDA+

J&J’s first pso­ri­a­sis study ex­clu­sive to pa­tients of col­or opens door to new mar­ket­ing com­mu­ni­ca­tions

Last year
Pharma
Marketing

2sev­en­ty bio stock drops 24% as com­pe­ti­tion catch­es up with BMS-part­nered mul­ti­ple myelo­ma drug

Last year
Pharma

No­var­tis sues Take­da af­ter for­mer em­ploy­ee al­leged­ly shared trade se­crets

Last year
Pharma
Law

Celebri­ty-backed pro­bi­otics start­up de­lays launch of sup­ple­ment mar­ket­ed with GLP-1 name

Last year
Health Tech

WuXi TIDES boosts oli­go, pep­tide of­fer­ings due to a rise in de­mand, with new builds on­go­ing

Last year
Manufacturing

Eu­ro­pean Com­mis­sion out­lines how coun­tries can share drugs to mit­i­gate short­ages

Last year
FDA+
Manufacturing

Mer­ck’s Keytru­da sales eclipse $18B on the year, while num­bers for Lagevrio sur­prise

Last year
R&D
Pharma

Bris­tol My­ers push­es back ‘peak’ for new prod­uct sales, cit­ing chal­leng­ing up­take for So­tyk­tu, Camzyos

Last year
R&D
Pharma

Man­aT Bio, a KRAS biotech from Bert Vo­gel­stein and Catalio, tar­gets $153M with Third Rock part­ner as CEO

Last year
Financing
Startups

Eu­roAPI CEO steps down; Sam­sung Bi­o­log­ics looks to Eu­rope; Mer­ck re­calls pneu­mo­coc­cal vac­cines

Last year
Manufacturing

Take­da takes $770M write­down on failed stem cell ther­a­py and with­drawn can­cer drug

Last year
Pharma

Like Mod­er­na, pan­dem­ic peers Pfiz­er and BioN­Tech head to PhI­II with Covid/flu com­bo jab

Last year
R&D
Pharma

Ther­mo Fish­er grows in­to CGT man­u­fac­tur­ing, while Sam­sung Bi­o­log­ics ex­pands in­to AD­Cs

Last year
Cell/Gene Tx
Manufacturing

Triveni Bio launch­es with $92M Se­ries A to fund eczema an­ti­body treat­ment

Last year
Financing

Zoc­doc’s CEO shares how the 16-year-old com­pa­ny weath­ered Covid-19, and why some start­up ideas fail

Last year
Health Tech
First page Previous page 256257258259260261262 Next page Last page
A service from the Financial Times